Načítá se...
23.2 ALPHA 7 NICOTINIC MODULATORS REVERSE THE HYPERDOPAMINERGIC TONE IN THE MAM MODEL OF SCHIZOPHRENIA
BACKGROUND: While dopaminergic antagonists have been the mainstay of schizophrenia pharmacotherapy, they suffer from low compliance and are fraught with side effects. A more effective approach would be to intervene at the site of dysfunction within the schizophrenia brain, which increasing evidence...
Uloženo v:
| Vydáno v: | Schizophr Bull |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6455873/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbz022.092 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|